Results 1 to 10 of about 18,434 (234)
Some of the next articles are maybe not open access.

IS OBESITY AN OUTCOME OF GONADOTROPIN RELEASING HORMONE AGONIST

2002
T. ARRIGO   +5 more
openaire   +1 more source

Gonadotropin-releasing hormone agonist-induced pituitary apoplexy [PDF]

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2016
Pituitary apoplexy represents an uncommon endocrine emergency with potentially life-threatening consequences. Drug-induced pituitary apoplexy is a rare but important consideration when evaluating patients with this presentation.
Fergus Keane   +4 more
doaj   +4 more sources

Pituitary Apoplexy Following Gonadotropin‐Releasing Hormone Agonist Administration for Prostate Cancer [PDF]

open access: yesIJU Case Reports
Introduction Pituitary apoplexy represents an uncommon endocrine emergency with potentially life‐threatening consequences. Gonadotropin‐releasing hormone agonist used for prostate cancer has the potential to induce pituitary apoplexy, particularly in the
Masaaki Fujimura   +5 more
doaj   +2 more sources

Gonadotropin-releasing hormone agonist contributes to the successful implementation of in vitro fertilization in a patient with cervical endometriosis: a case report

open access: yesAJOG Global Reports, 2023
This is a case report of a nulliparous young woman who suffered from prolonged menstruation and infertility for 1 year. Magnetic resonance imaging and a transvaginal ultrasound examination revealed cervical endometriosis.
Turui Yang, MD   +4 more
doaj   +2 more sources

Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist [PDF]

open access: yesEndocrinology and Metabolism, 2013
Gonadotropin-releasing hormone (GnRH) agonist has been used in the treatment of a wide variety of sex-hormone-related diseases, as the administration of GnRH agonist can alter the secretion of gonadotropin and sex hormones.
Eun Jin Han   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy